High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia

Published:2020-01-24 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Müller Stephan,Bexte Tobias,Gebel Veronika,Kalensee Franziska,Stolzenberg Eva,Hartmann Jessica,Koehl Ulrike,Schambach Axel,Wels Winfried S.,Modlich Ute,Ullrich Evelyn

Funder

Deutsche Forschungsgemeinschaft

Deutschen Konsortium für Translationale Krebsforschung

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference63 articles.

1. Treatment of relapsed/refractory acute lymphoblastic leukemia;Paul;Clin Adv Hematol Oncol,2019

2. Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation;Gökbuget;Blood,2012

3. Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study;Sun;Leukemia,2018

4. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia;Brentjens;Sci Transl Med,2013

5. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia;Grupp;N Engl J Med,2013

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing lentiviral vector formulation conditions for efficient ex vivo transduction of primary human T cells in chimeric antigen receptor T-cell manufacturing;Cytotherapy;2024-09

2. T cell receptor-directed antibody-drug conjugates for the treatment of T cell-derived cancers;Molecular Therapy: Oncology;2024-09

3. Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy;Pharmaceutics;2024-08-29

4. Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy;Journal of Translational Medicine;2024-08-05

5. The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity;Cancers;2024-07-22